Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.

Bradley CP, Chen C, Oetjen KA, Yan C, Panjwani R, Hauffe S, Calvo KR, Yuan C, Patel PA, Montgomery ND, Foster MC, Battiwalla M, Barrett AJ, Gibbons RJ, Ito S.

Blood Adv. 2019 Sep 10;3(17):2627-2631. doi: 10.1182/bloodadvances.2019000013. No abstract available.

2.

Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups.

Xue X, Foster MC, Ivanova A.

J Biopharm Stat. 2019;29(4):625-634. doi: 10.1080/10543406.2019.1633654. Epub 2019 Jun 28.

PMID:
31251112
3.

Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1.

Peterschmitt MJ, Freisens S, Underhill LH, Foster MC, Lewis G, Gaemers SJM.

Orphanet J Rare Dis. 2019 Jun 7;14(1):128. doi: 10.1186/s13023-019-1085-6.

4.

Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation.

Bates JS, Auten J, Sketch MR, Patel T, Clark SM, Morgan KP, Muluneh B, McLaughlin JE, Pinelli NR, Foster MC, Amerine L.

J Oncol Pharm Pract. 2019 Jun;25(4):896-902. doi: 10.1177/1078155219832644. Epub 2019 Feb 26.

PMID:
30808278
5.

The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors.

Copeland AC, Foster MC, Muluneh B, Xenakis JG, Ivanova A, Frankfurt O, Clayton M, Black A, Rapchak B, Wehbie RS.

Leuk Lymphoma. 2019 Jul;60(7):1842-1844. doi: 10.1080/10428194.2018.1551540. Epub 2019 Feb 18. No abstract available.

PMID:
30773105
6.

Effects of a Cookstove Intervention on Cardiac Structure, Cardiac Function, and Blood Pressure in Western Kenya.

Bloomfield GS, Kirwa K, Agarwal A, Eliot MN, Alenezi F, Carter EJ, Foster MC, Kimaiyo S, Lumsden R, Menya D, Mitter SS, Velazquez EJ, Vedanthan R, Wellenius GA.

J Am Soc Echocardiogr. 2019 Mar;32(3):427-430. doi: 10.1016/j.echo.2018.11.013. Epub 2019 Jan 18. No abstract available.

PMID:
30665729
7.

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.

Stock W, Luger SM, Advani AS, Yin J, Harvey RC, Mullighan CG, Willman CL, Fulton N, Laumann KM, Malnassy G, Paietta E, Parker E, Geyer S, Mrózek K, Bloomfield CD, Sanford B, Marcucci G, Liedtke M, Claxton DF, Foster MC, Bogart JA, Grecula JC, Appelbaum FR, Erba H, Litzow MR, Tallman MS, Stone RM, Larson RA.

Blood. 2019 Apr 4;133(14):1548-1559. doi: 10.1182/blood-2018-10-881961. Epub 2019 Jan 18.

PMID:
30658992
8.

Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography.

Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, Horton K, Ogunyankin KO, Palma RA, Velazquez EJ.

J Am Soc Echocardiogr. 2019 Jan;32(1):1-64. doi: 10.1016/j.echo.2018.06.004. Epub 2018 Oct 1. No abstract available.

PMID:
30282592
9.

Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial.

Lukina E, Watman N, Dragosky M, Lau H, Avila Arreguin E, Rosenbaum H, Zimran A, Foster MC, Gaemers SJM, Peterschmitt MJ.

Am J Hematol. 2019 Jan;94(1):29-38. doi: 10.1002/ajh.25300. Epub 2018 Oct 26.

10.

Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML).

Zeidner JF, Foster MC, Blackford AL, Litzow MR, Morris LE, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Little RF, Wright JJ, Doyle LA, Smith BD, Karp JE.

Leuk Res. 2018 Sep;72:92-95. doi: 10.1016/j.leukres.2018.08.005. Epub 2018 Aug 10. No abstract available.

PMID:
30118897
11.

Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatment.

Yogarajah M, Montgomery N, Matson M, Blanchard L, Frank C, Gallagher S, Pepin K, Vaught L, Muluneh B, Foster MC, Zeidner JF.

Leuk Lymphoma. 2018 Dec;59(12):3010-3012. doi: 10.1080/10428194.2018.1459614. Epub 2018 May 11. No abstract available.

PMID:
29749763
12.

Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk.

Mongraw-Chaffin M, Foster MC, Anderson CAM, Burke GL, Haq N, Kalyani RR, Ouyang P, Sibley CT, Tracy R, Woodward M, Vaidya D.

J Am Coll Cardiol. 2018 May 1;71(17):1857-1865. doi: 10.1016/j.jacc.2018.02.055.

13.

Autonomous Thermal-Oxidative Composition Inversion and Texture Tuning of Liquid Metal Surfaces.

Cutinho J, Chang BS, Oyola-Reynoso S, Chen J, Akhter SS, Tevis ID, Bello NJ, Martin A, Foster MC, Thuo MM.

ACS Nano. 2018 May 22;12(5):4744-4753. doi: 10.1021/acsnano.8b01438. Epub 2018 Apr 16.

PMID:
29648786
14.

Immunomodulatory and Antibacterial Properties of the Chumash Medicinal Plant Trichostema lanatum.

Fleming MC, Hester V, Allison BJ, Foster MC, Nofziger D, Joyner PM.

Medicines (Basel). 2018 Mar 21;5(2). pii: E25. doi: 10.3390/medicines5020025.

15.

The Association of Percent Body Fat and Lean Mass With HbA1c in US Adults.

Bower JK, Meadows RJ, Foster MC, Foraker RE, Shoben AB.

J Endocr Soc. 2017 Apr 18;1(6):600-608. doi: 10.1210/js.2017-00046. eCollection 2017 Jun 1.

16.

A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML.

Muluneh B, Buhlinger K, Deal AM, Zeidner JF, Foster MC, Jamieson KJ, Bates J, Van Deventer HW.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e13-e18. doi: 10.1016/j.clml.2017.09.016. Epub 2017 Sep 22.

PMID:
29100976
17.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2017 Oct;70(4):551-560. doi: 10.1053/j.ajkd.2017.04.025. Epub 2017 Jun 23.

18.

The Effects of Exercise on Patient-Reported Outcomes and Performance-Based Physical Function in Adults With Acute Leukemia Undergoing Induction Therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL).

Bryant AL, Deal AM, Battaglini CL, Phillips B, Pergolotti M, Coffman E, Foster MC, Wood WA, Bailey C, Hackney AC, Mayer DK, Muss HB, Reeve BB.

Integr Cancer Ther. 2018 Jun;17(2):263-270. doi: 10.1177/1534735417699881. Epub 2017 Mar 24.

19.

Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.

Merhi B, Shireman T, Carpenter MA, Kusek JW, Jacques P, Pfeffer M, Rao M, Foster MC, Kim SJ, Pesavento TE, Smith SR, Kew CE, House AA, Gohh R, Weiner DE, Levey AS, Ix JH, Bostom A.

Am J Kidney Dis. 2017 Sep;70(3):377-385. doi: 10.1053/j.ajkd.2017.04.014. Epub 2017 Jun 2.

20.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.

Foster MC, Levey AS, Inker LA, Shafi T, Fan L, Gudnason V, Katz R, Mitchell GF, Okparavero A, Palsson R, Post WS, Shlipak MG.

Am J Kidney Dis. 2017 Sep;70(3):406-414. doi: 10.1053/j.ajkd.2017.03.021. Epub 2017 May 24.

21.

Improving on the diagnostic characteristics of echocardiography for pulmonary hypertension.

Broderick-Forsgren K, Davenport CA, Sivak JA, Hargett CW, Foster MC, Monteagudo A, Armour A, Rajagopal S, Arges K, Velazquez EJ, Samad Z.

Int J Cardiovasc Imaging. 2017 Sep;33(9):1341-1349. doi: 10.1007/s10554-017-1114-2. Epub 2017 Mar 24.

PMID:
28337558
22.

Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.

Foster MC, Weiner DE, Bostom AG, Carpenter MA, Inker LA, Jarolim P, Joseph AA, Kusek JW, Pesavento T, Pfeffer MA, Rao M, Solomon SD, Levey AS.

Am J Transplant. 2017 Sep;17(9):2390-2399. doi: 10.1111/ajt.14258. Epub 2017 Mar 30.

23.

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

Inker LA, Coresh J, Sang Y, Hsu CY, Foster MC, Eckfeldt JH, Karger AB, Nelson RG, Liu X, Sarnak M, Appel LJ, Grams M, Xie D, Kimmel PL, Feldman H, Ramachandran V, Levey AS; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):69-78. doi: 10.2215/CJN.03660316. Epub 2016 Nov 10.

24.

Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant Recipients.

Hauck CG, Chong PP, Miller MB, Jamieson K, Fine JP, Foster MC, Shea TC, van Duin D.

Pathog Immun. 2016 Fall-Winter;1(2):234-242. doi: 10.20411/pai.v1i2.115.

25.

Obesity Severity and Duration Are Associated With Incident Metabolic Syndrome: Evidence Against Metabolically Healthy Obesity From the Multi-Ethnic Study of Atherosclerosis.

Mongraw-Chaffin M, Foster MC, Kalyani RR, Vaidya D, Burke GL, Woodward M, Anderson CA.

J Clin Endocrinol Metab. 2016 Nov;101(11):4117-4124. Epub 2016 Aug 23.

26.

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.

Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, Wu G, Li Y, Wei L, Iacobucci I, Liu Y, Qu C, Wen J, Edmonson M, Payne-Turner D, Kaufmann KB, Takayanagi SI, Wienholds E, Waanders E, Ntziachristos P, Bakogianni S, Wang J, Aifantis I, Roberts KG, Ma J, Song G, Easton J, Mulder HL, Chen X, Newman S, Ma X, Rusch M, Gupta P, Boggs K, Vadodaria B, Dalton J, Liu Y, Valentine ML, Ding L, Lu C, Fulton RS, Fulton L, Tabib Y, Ochoa K, Devidas M, Pei D, Cheng C, Yang J, Evans WE, Relling MV, Pui CH, Jeha S, Harvey RC, Chen IL, Willman CL, Marcucci G, Bloomfield CD, Kohlschmidt J, Mrózek K, Paietta E, Tallman MS, Stock W, Foster MC, Racevskis J, Rowe JM, Luger S, Kornblau SM, Shurtleff SA, Raimondi SC, Mardis ER, Wilson RK, Dick JE, Hunger SP, Loh ML, Downing JR, Mullighan CG; St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project.

Nat Genet. 2016 Dec;48(12):1481-1489. doi: 10.1038/ng.3691. Epub 2016 Oct 24.

27.

The Limitations and Promise of Immunotherapy With Chimeric Antigen-Modified T Cells.

Ranganathan R, Foster MC.

Oncology (Williston Park). 2016 Oct 15;30(10):889-90. No abstract available.

28.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.

Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS; CRIC (Chronic Renal Insufficiency Cohort) Study Investigators.

Am J Kidney Dis. 2016 Dec;68(6):892-900. doi: 10.1053/j.ajkd.2016.07.021. Epub 2016 Sep 20.

29.

Comparison of techniques for culture of dialysis water and fluid.

Maltais JB, Meyer KB, Foster MC.

Hemodial Int. 2017 Apr;21(2):197-205. doi: 10.1111/hdi.12477. Epub 2016 Sep 5.

PMID:
27594052
30.

Kidney Transplants from HLA-Incompatible Live Donors and Survival.

Dad T, Foster MC, Weiner DE.

N Engl J Med. 2016 Jul 21;375(3):288. doi: 10.1056/NEJMc1604523. No abstract available.

PMID:
27468076
31.

A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma.

Park SI, Grover NS, Olajide O, Asch AS, Wall JG, Richards KL, Sobol AL, Deal AM, Ivanova A, Foster MC, Muss HB, Shea TC.

Br J Haematol. 2016 Oct;175(2):281-289. doi: 10.1111/bjh.14232. Epub 2016 Jul 22.

32.

Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Waikar SS, Sabbisetti V, Ärnlöv J, Carlsson AC, Coresh J, Feldman HI, Foster MC, Fufaa GD, Helmersson-Karlqvist J, Hsu CY, Kimmel PL, Larsson A, Liu Y, Lind L, Liu KD, Mifflin TE, Nelson RG, Risérus U, Vasan RS, Xie D, Zhang X, Bonventre JV; Chronic Kidney Disease Biomarkers Consortium Investigators.

Nephrol Dial Transplant. 2016 Sep;31(9):1460-70. doi: 10.1093/ndt/gfw203. Epub 2016 Jun 7.

33.

Aortic stiffness and change in glomerular filtration rate and albuminuria in older people.

Huang N, Foster MC, Mitchell GF, Andresdottir MB, Eiriksdottir G, Gudmundsdottir H, Harris TB, Launer LJ, Palsson R, Gudnason V, Levey AS, Inker LA.

Nephrol Dial Transplant. 2017 Apr 1;32(4):677-684. doi: 10.1093/ndt/gfw050.

34.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA; CKD Biomarker Consortium and the CRIC Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):68-76. doi: 10.1053/j.ajkd.2016.01.015. Epub 2016 Mar 3.

35.

The rapid enrollment design for Phase I clinical trials.

Ivanova A, Wang Y, Foster MC.

Stat Med. 2016 Jul 10;35(15):2516-24. doi: 10.1002/sim.6886. Epub 2016 Feb 1.

36.

Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya.

Binanay CA, Akwanalo CO, Aruasa W, Barasa FA, Corey GR, Crowe S, Esamai F, Einterz R, Foster MC, Gardner A, Kibosia J, Kimaiyo S, Koech M, Korir B, Lawrence JE, Lukas S, Manji I, Maritim P, Ogaro F, Park P, Pastakia SD, Sugut W, Vedanthan R, Yanoh R, Velazquez EJ, Bloomfield GS.

J Am Coll Cardiol. 2015 Dec 8;66(22):2550-60. doi: 10.1016/j.jacc.2015.09.086. Review.

37.

Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.

Teumer A, Tin A, Sorice R, Gorski M, Yeo NC, Chu AY, Li M, Li Y, Mijatovic V, Ko YA, Taliun D, Luciani A, Chen MH, Yang Q, Foster MC, Olden M, Hiraki LT, Tayo BO, Fuchsberger C, Dieffenbach AK, Shuldiner AR, Smith AV, Zappa AM, Lupo A, Kollerits B, Ponte B, Stengel B, Krämer BK, Paulweber B, Mitchell BD, Hayward C, Helmer C, Meisinger C, Gieger C, Shaffer CM, Müller C, Langenberg C, Ackermann D, Siscovick D; DCCT/EDIC, Boerwinkle E, Kronenberg F, Ehret GB, Homuth G, Waeber G, Navis G, Gambaro G, Malerba G, Eiriksdottir G, Li G, Wichmann HE, Grallert H, Wallaschofski H, Völzke H, Brenner H, Kramer H, Mateo Leach I, Rudan I, Hillege HL, Beckmann JS, Lambert JC, Luan J, Zhao JH, Chalmers J, Coresh J, Denny JC, Butterbach K, Launer LJ, Ferrucci L, Kedenko L, Haun M, Metzger M, Woodward M, Hoffman MJ, Nauck M, Waldenberger M, Pruijm M, Bochud M, Rheinberger M, Verweij N, Wareham NJ, Endlich N, Soranzo N, Polasek O, van der Harst P, Pramstaller PP, Vollenweider P, Wild PS, Gansevoort RT, Rettig R, Biffar R, Carroll RJ, Katz R, Loos RJ, Hwang SJ, Coassin S, Bergmann S, Rosas SE, Stracke S, Harris TB, Corre T, Zeller T, Illig T, Aspelund T, Tanaka T, Lendeckel U, Völker U, Gudnason V, Chouraki V, Koenig W, Kutalik Z, O'Connell JR, Parsa A, Heid IM, Paterson AD, de Boer IH, Devuyst O, Lazar J, Endlich K, Susztak K, Tremblay J, Hamet P, Jacob HJ, Böger CA, Fox CS, Pattaro C, Köttgen A.

Diabetes. 2016 Mar;65(3):803-17. doi: 10.2337/db15-1313. Epub 2015 Dec 2.

38.

Estimated GFR for Living Kidney Donor Evaluation.

Huang N, Foster MC, Lentine KL, Garg AX, Poggio ED, Kasiske BL, Inker LA, Levey AS.

Am J Transplant. 2016 Jan;16(1):171-80. doi: 10.1111/ajt.13540. Epub 2015 Nov 23.

39.

Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute.

Zeidner JF, Karp JE, Blackford AL, Foster MC, Dees EC, Smith G, Ivy SP, Harris P.

J Natl Cancer Inst. 2015 Nov 9;108(3). doi: 10.1093/jnci/djv335. Print 2016 Mar.

40.

Prevalence and complications of chronic kidney disease in a representative elderly population in Iceland.

Okparavero A, Foster MC, Tighiouart H, Gudnason V, Indridason O, Gudmundsdottir H, Eiriksdottir G, Gudmundsson EF, Inker LA, Levey AS.

Nephrol Dial Transplant. 2016 Mar;31(3):439-47. doi: 10.1093/ndt/gfv370. Epub 2015 Oct 31.

41.

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS.

Am J Kidney Dis. 2016 Jan;67(1):40-8. doi: 10.1053/j.ajkd.2015.07.025. Epub 2015 Sep 9.

42.

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, Nelson RG, Grams M, Feldman HI, Vasan RS, Kimmel PL, Hsu CY, Liu KD; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1956-63. doi: 10.2215/CJN.02590315. Epub 2015 Sep 8.

43.

Estimation of Life-Years Saved by Solid-Organ Transplant.

Foster MC, Varothai N, Weiner DE.

JAMA Surg. 2015 Oct;150(10):1015. doi: 10.1001/jamasurg.2015.1936. No abstract available.

PMID:
26244845
44.

Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia.

Zeidner JF, Foster MC, Blackford AL, Litzow MR, Morris LE, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Little RF, Wright JJ, Doyle LA, Smith BD, Karp JE.

Haematologica. 2015 Sep;100(9):1172-9. doi: 10.3324/haematol.2015.125849. Epub 2015 May 28.

45.

Lifestyle factors and indices of kidney function in the Framingham Heart Study.

Foster MC, Hwang SJ, Massaro JM, Jacques PF, Fox CS, Chu AY.

Am J Nephrol. 2015;41(4-5):267-74. doi: 10.1159/000430868. Epub 2015 May 20.

46.

Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.

Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):941-8. doi: 10.2215/CJN.10101014. Epub 2015 Mar 30.

47.

Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.

Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG; CKD Biomarkers Consortium.

Am J Kidney Dis. 2015 Jul;66(1):75-83. doi: 10.1053/j.ajkd.2015.01.013. Epub 2015 Mar 12.

48.

Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML).

Zeidner JF, Foster MC.

Curr Drug Targets. 2017;18(3):304-314. doi: 10.2174/1389450116666150304104315. Review.

PMID:
25738295
49.
50.

Lenalidomide-associated hemolytic anemia.

Lim MY, Raval JS, Richards KL, Zeidner JF, Foster MC.

Leuk Lymphoma. 2015;56(9):2717-9. doi: 10.3109/10428194.2014.1003558. Epub 2015 Mar 2. No abstract available.

PMID:
25644743

Supplemental Content

Loading ...
Support Center